Home › Companies › Indivior Pharmaceuticals, Inc. › 2025-2026

Indivior Pharmaceuticals, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Indivior Pharmaceuticals, Inc.’s Form 8-K, filed May 15, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 20Reported items
  • 303Asset managers
  • 5,333Fund votes
  • May 13, 2026Main meeting date

Results at a glance

Meeting of May 13, 2026: 11 items on Indivior Pharmaceuticals, Inc.’s Form 8-K, filed May 15, 2026: 11 without a stated outcome.

Meeting of December 11, 2025: 5 items on Indivior Pharmaceuticals, Inc.’s Form 8-K, filed December 15, 2025: 5 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2025-2026

Explore Indivior Pharmaceuticals, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Indivior Pharmaceuticals, Inc.

These tallies are Indivior Pharmaceuticals, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. Indivior Pharmaceuticals, Inc. reported 2 meetings in this season; each is tabulated separately below, with its own filing.

Indivior Pharmaceuticals, Inc. — official shareholder meeting results, meeting held May 13, 2026 (Form 8-K, filed May 15, 2026)
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Dr. David Wheadon 91,378,8281,534,06424,804 --7,470,026 98%Not verified—
Elect Director: Joe Ciaffoni 92,834,81176,83926,046 --7,470,026 99.9%Not verified—
Elect Director: Dr. Keith Humphreys 92,839,95572,08425,657 --7,470,026 99.9%Not verified—
Elect Director: Tony Kingsley 92,839,46972,50325,724 --7,470,026 99.9%Not verified—
Elect Director: Daniel Ninivaggi 87,545,0325,366,84925,815 --7,470,026 94%Not verified—
Elect Director: Barbara Ryan 91,562,1951,302,38373,118 --7,470,026 99%Not verified—
Elect Director: Mark Stejbach 92,838,96272,84725,887 --7,470,026 99.9%Not verified—
Elect Director: Juliet Thompson 92,136,342728,04073,314 --7,470,026 99.2%Not verified—
2. To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement (Say-on-Pay) 90,364,5661,324,9961,248,134 --7,470,026 99%Not verified—
3. To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers (Say-on-Frequency) 91,848,954--34,100 --7,470,026 —Not verified—
4. To ratify the appointment of PricewaterhouseCoopers LLP US (PwC) as our independent registered public accounting firm for the fiscal year ending December 31, 2026 99,146,2411,237,98423,497 --0 99%Not verified—

Source: Indivior Pharmaceuticals, Inc., Form 8-K, filed with the SEC on May 15, 2026 — read the filing on EDGAR.

Indivior Pharmaceuticals, Inc. — official shareholder meeting results, meeting held December 11, 2025 (Form 8-K, filed December 15, 2025)
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
2. To authorise the reduction of share capital 79,648,08324,302-- 15,327-- 99.9%Not verified—
3. To authorise (a) the paying up, allotment and issuance of New Indivior Shares, and (b) the Directors to allot such New Indivior Shares 78,547,0771,126,760-- 13,875-- 99%Not verified—
4. To authorise the amendment to the articles of association 79,653,74022,803-- 11,169-- 99.9%Not verified—
5. To authorise the re-registration of the Company as a private company limited by shares 79,657,07026,320-- 4,322-- 99.9%Not verified—
6. To authorise the adoption of the Post-Scheme Articles of Association 79,655,89320,231-- 11,588-- 99.9%Not verified—

Source: Indivior Pharmaceuticals, Inc., Form 8-K, filed with the SEC on December 15, 2025 — read the filing on EDGAR.

How asset managers voted at the Indivior Pharmaceuticals, Inc. 2025-2026 meetings

Each item below shows how the 303 asset managers that disclosed a Indivior Pharmaceuticals, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Indivior Pharmaceuticals, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Barbara Ryan

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held May 13, 2026.

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 91,562,195AGAINST: 1,302,383
Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: Election of Directors: Barbara Ryan

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Barbara Ryan”): 91,562,195 for, 1,302,383 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 35,533,537 for, 9,851 against, 19,753 abstained.

FOR
FOR: 35,533,537AGAINST: 9,851ABSTAIN: 19,753
Largest asset managers voting on “Election of Directors: Barbara Ryan” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,290,2423 00For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle194,1460 00For
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Empower90,7420 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

2. Elect Director: Daniel Ninivaggi

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held May 13, 2026.

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 87,545,032AGAINST: 5,366,849
Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: Election of Directors: Daniel Ninivaggi

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Daniel Ninivaggi”): 87,545,032 for, 5,366,849 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 35,322,702 for, 220,687 against, 19,753 abstained.

FOR
FOR: 35,322,702AGAINST: 220,687ABSTAIN: 19,753
Largest asset managers voting on “Election of Directors: Daniel Ninivaggi” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,273,55316,693 00For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle0194,146 00Against
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Empower90,7420 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

3. Elect Director: Dr. David Wheadon

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held May 13, 2026.

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 91,378,828AGAINST: 1,534,064
Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: Election of Directors: Dr. David Wheadon

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Dr. David Wheadon”): 91,378,828 for, 1,534,064 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 35,516,869 for, 26,520 against, 19,753 abstained.

FOR
FOR: 35,516,869AGAINST: 26,520ABSTAIN: 19,753
Largest asset managers voting on “Election of Directors: Dr. David Wheadon” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,273,57416,672 00For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle194,1460 00For
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Empower90,7420 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

4. Elect Director: Dr. Keith Humphreys

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held May 13, 2026.

Combines 4 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 92,839,955AGAINST: 72,084
Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: Election of Directors: Dr. Keith Humphreys

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Dr. Keith Humphreys”): 92,839,955 for, 72,084 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 35,543,389 for, 19,753 abstained.

FOR
FOR: 35,543,389ABSTAIN: 19,753
Largest asset managers voting on “Election of Directors: Dr. Keith Humphreys” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,290,2460 00For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle194,1460 00For
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Empower90,7420 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

5. Elect Director: Joe Ciaffoni

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held May 13, 2026.

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 92,834,811AGAINST: 76,839
Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: Election of Directors: Joe Ciaffoni

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Joe Ciaffoni”): 92,834,811 for, 76,839 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 35,543,389 for, 19,753 abstained.

FOR
FOR: 35,543,389ABSTAIN: 19,753
Largest asset managers voting on “Election of Directors: Joe Ciaffoni” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,290,2460 00For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle194,1460 00For
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Empower90,7420 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

6. Elect Director: Juliet Thompson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held May 13, 2026.

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 92,136,342AGAINST: 728,040
Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: Election of Directors: Juliet Thompson

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Juliet Thompson”): 92,136,342 for, 728,040 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 35,533,539 for, 9,850 against, 19,753 abstained.

FOR
FOR: 35,533,539AGAINST: 9,850ABSTAIN: 19,753
Largest asset managers voting on “Election of Directors: Juliet Thompson” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,290,2442 00For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle194,1460 00For
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Empower90,7420 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

7. Elect Director: Mark Stejbach

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held May 13, 2026.

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 92,838,962AGAINST: 72,847
Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: Election of Directors: Mark Stejbach

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Mark Stejbach”): 92,838,962 for, 72,847 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 35,543,389 for, 19,753 abstained.

FOR
FOR: 35,543,389ABSTAIN: 19,753
Largest asset managers voting on “Election of Directors: Mark Stejbach” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,290,2460 00For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle194,1460 00For
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Empower90,7420 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

8. Elect Director: Tony Kingsley

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held May 13, 2026.

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 92,839,469AGAINST: 72,503
Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: Election of Directors: Tony Kingsley

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Tony Kingsley”): 92,839,469 for, 72,503 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 35,543,389 for, 19,753 abstained.

FOR
FOR: 35,543,389ABSTAIN: 19,753
Largest asset managers voting on “Election of Directors: Tony Kingsley” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,290,2460 00For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle194,1460 00For
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Empower90,7420 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

9. 5. To authorise the re-registration of the Company as a private company limited by shares

Outcome not verifiedEXTRAORDINARY TRANSACTIONSReported outcome: Not verified

Meeting held December 11, 2025.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 79,657,070AGAINST: 26,320
Details: description as filed, official tally, votes by 79 asset managers

Description as filed by funds: Approve Re-registration of the Company as a Private Company by the Name of Indivior Limited

Indivior Pharmaceuticals, Inc.’s own tally for this item (“5. To authorise the re-registration of the Company as a private company limited by shares”): 79,657,070 for, 26,320 against, per its Form 8-K filed December 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 79 asset managers below reported 23,020,233 for.

FOR
FOR: 23,020,233
Largest asset managers voting on “Approve Re-registration of the Company as a Private Company by the Name of Indivior Limited” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust5,066,9590 00For
BlackRock4,431,6090 00For
Vanguard3,148,9710 00For
Fidelity2,631,8270 00For
Charles Schwab1,151,4230 00For
TIAA928,7220 00For
Victory Capital531,2530 00For
OBERWEIS FUNDS424,9410 00For
Federated Hermes398,7580 00For
Pacer Funds Trust345,9400 00For
DRIEHAUS MUTUAL FUNDS344,5120 00For
American Century314,6940 00For
Royce305,7100 00For
Equitable268,3360 00For
Dimensional239,3090 00For
SEI238,0870 00For
QUANTITATIVE MASTER SERIES LLC202,4920 00For
Lincoln Financial180,3220 00For
Thrivent140,2340 00For
Calamos112,8560 00For
Principal Exchange-Traded Funds92,8670 00For
Prudential/PGIM81,7480 00For
Northern Trust80,2660 00For
TARGET PORTFOLIO TRUST77,7000 00For
Voya74,0260 00For

Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.

10. Approve Scheme of Arrangement

No official matchEXTRAORDINARY TRANSACTIONS

Meeting held December 11, 2025.

100% of fund votes cast · no official result

FOR
Details: votes by 53 asset managers

The 53 asset managers below reported 15,701,308 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 15,701,308
Largest asset managers voting on “Approve Scheme of Arrangement” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust5,066,9590 00For
Vanguard3,148,9710 00For
Fidelity2,631,8270 00For
TIAA928,7220 00For
Victory Capital531,2530 00For
OBERWEIS FUNDS424,9410 00For
DRIEHAUS MUTUAL FUNDS344,5120 00For
American Century314,6940 00For
Royce305,7100 00For
Equitable268,3360 00For
Dimensional239,3090 00For
Lincoln Financial180,3220 00For
Thrivent140,2340 00For
Principal Exchange-Traded Funds92,8670 00For
Northern Trust80,2660 00For
Voya74,0260 00For
RBB FUND, INC.66,7510 00For
OLD WESTBURY FUNDS INC66,6290 00For
AIG/SunAmerica59,7110 00For
Prudential/PGIM59,4500 00For
State Street44,7030 00For
Nationwide44,4950 00For
Brighthouse43,4280 00For
MFS43,1220 00For
JPMorgan42,5060 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

11. To approve the Scheme as set forth in the Scheme Circular.

Meeting held December 11, 2025.

Combines 2 wordings of this item as funds reported it.

99.9% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 32 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 29 asset managers voting on “To approve the Scheme as set forth in the Scheme Circular.” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock4,431,6090 00For
Charles Schwab1,151,4230 00For
Federated Hermes398,7580 00For
Pacer Funds Trust345,9400 00For
SEI238,0870 00For
QUANTITATIVE MASTER SERIES LLC202,4920 00For
Calamos112,8560 00For
TARGET PORTFOLIO TRUST77,7000 00For
Global X58,2890 00For
TRUST FOR PROFESSIONAL MANAGERS57,8690 00For
Jackson National51,3210 00For
John Hancock37,7040 00For
Bridge Builder Trust28,1300 00For
MASTER INVESTMENT PORTFOLIO27,9170 00For
Prudential/PGIM22,2980 00For
New York Life16,8060 00For
Russell Investments10,9070 00For
Venerable Variable Insurance Trust9,9140 00For
TIFF INVESTMENT PROGRAM8,7320 00For
NYLIM VP FUNDS TRUST8,0650 00For
Brighthouse07,245 00Against
GoldenTree Opportunistic Credit Fund3,3180 00For
Nationwide2,9620 00For
Simplify Exchange Traded Funds2,6710 00For
WILSHIRE MUTUAL FUNDS INC2,0020 00For

Fund voting reports, all 29 managers: 7,310,032 for, 7,245 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “To approve the Scheme as set forth in the Scheme Circular.” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Alta Fundamental Advisers LLC464,0490 00For
Jackson Creek Investment Advisors LLC4660 00For

Institutional-manager reports, all 2 managers: 464,515 for.

12. To authorise the Directors to take all necessary action to give effect to the Scheme

No official matchCAPITAL STRUCTURE

Meeting held December 11, 2025.

99.9% of fund votes cast · no official result

FOR
Details: votes by 31 asset managers

The 31 asset managers below reported 7,311,680 for, 7,245 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 7,311,680WITHHOLD: 7,245
Largest asset managers voting on “To authorise the Directors to take all necessary action to give effect to the Scheme” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock4,431,6090 00For
Charles Schwab1,151,4230 00For
Federated Hermes398,7580 00For
Pacer Funds Trust345,9400 00For
SEI238,0870 00For
QUANTITATIVE MASTER SERIES LLC202,4920 00For
Calamos112,8560 00For
TARGET PORTFOLIO TRUST77,7000 00For
Global X58,2890 00For
TRUST FOR PROFESSIONAL MANAGERS57,8690 00For
Jackson National51,3210 00For
John Hancock37,7040 00For
Bridge Builder Trust28,1300 00For
MASTER INVESTMENT PORTFOLIO27,9170 00For
Prudential/PGIM22,2980 00For
New York Life16,8060 00For
Russell Investments10,9070 00For
Venerable Variable Insurance Trust9,9140 00For
TIFF INVESTMENT PROGRAM8,7320 00For
NYLIM VP FUNDS TRUST8,0650 00For
Brighthouse00 07,245Withhold
GoldenTree Opportunistic Credit Fund3,3180 00For
Nationwide2,9620 00For
Simplify Exchange Traded Funds2,6710 00For
WILSHIRE MUTUAL FUNDS INC2,0020 00For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

13. 4. To authorise the amendment to the articles of association

Outcome not verifiedCORPORATE GOVERNANCEReported outcome: Not verified

Meeting held December 11, 2025.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 79,653,740AGAINST: 22,803
Details: description as filed, official tally, votes by 79 asset managers

Description as filed by funds: Amend Articles of Association

Indivior Pharmaceuticals, Inc.’s own tally for this item (“4. To authorise the amendment to the articles of association”): 79,653,740 for, 22,803 against, per its Form 8-K filed December 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 79 asset managers below reported 23,012,988 for, 7,245 withheld.

FOR
FOR: 23,012,988WITHHOLD: 7,245
Largest asset managers voting on “Amend Articles of Association” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust5,066,9590 00For
BlackRock4,431,6090 00For
Vanguard3,148,9710 00For
Fidelity2,631,8270 00For
Charles Schwab1,151,4230 00For
TIAA928,7220 00For
Victory Capital531,2530 00For
OBERWEIS FUNDS424,9410 00For
Federated Hermes398,7580 00For
Pacer Funds Trust345,9400 00For
DRIEHAUS MUTUAL FUNDS344,5120 00For
American Century314,6940 00For
Royce305,7100 00For
Equitable268,3360 00For
Dimensional239,3090 00For
SEI238,0870 00For
QUANTITATIVE MASTER SERIES LLC202,4920 00For
Lincoln Financial180,3220 00For
Thrivent140,2340 00For
Calamos112,8560 00For
Principal Exchange-Traded Funds92,8670 00For
Prudential/PGIM81,7480 00For
Northern Trust80,2660 00For
TARGET PORTFOLIO TRUST77,7000 00For
Voya74,0260 00For

Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.

14. 6. To authorise the adoption of the Post-Scheme Articles of Association

Outcome not verifiedCORPORATE GOVERNANCEReported outcome: Not verified

Meeting held December 11, 2025.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 79,655,893AGAINST: 20,231
Details: description as filed, official tally, votes by 79 asset managers

Description as filed by funds: Adopt New Articles of Association

Indivior Pharmaceuticals, Inc.’s own tally for this item (“6. To authorise the adoption of the Post-Scheme Articles of Association”): 79,655,893 for, 20,231 against, per its Form 8-K filed December 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 79 asset managers below reported 23,012,988 for, 7,245 withheld.

FOR
FOR: 23,012,988WITHHOLD: 7,245
Largest asset managers voting on “Adopt New Articles of Association” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust5,066,9590 00For
BlackRock4,431,6090 00For
Vanguard3,148,9710 00For
Fidelity2,631,8270 00For
Charles Schwab1,151,4230 00For
TIAA928,7220 00For
Victory Capital531,2530 00For
OBERWEIS FUNDS424,9410 00For
Federated Hermes398,7580 00For
Pacer Funds Trust345,9400 00For
DRIEHAUS MUTUAL FUNDS344,5120 00For
American Century314,6940 00For
Royce305,7100 00For
Equitable268,3360 00For
Dimensional239,3090 00For
SEI238,0870 00For
QUANTITATIVE MASTER SERIES LLC202,4920 00For
Lincoln Financial180,3220 00For
Thrivent140,2340 00For
Calamos112,8560 00For
Principal Exchange-Traded Funds92,8670 00For
Prudential/PGIM81,7480 00For
Northern Trust80,2660 00For
TARGET PORTFOLIO TRUST77,7000 00For
Voya74,0260 00For

Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.

15. 2. To authorise the reduction of share capital

Outcome not verifiedCAPITAL STRUCTUREReported outcome: Not verified

Meeting held December 11, 2025.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 79,648,083AGAINST: 24,302
Details: description as filed, official tally, votes by 79 asset managers

Description as filed by funds: Approve Reduction in Share Capital

Indivior Pharmaceuticals, Inc.’s own tally for this item (“2. To authorise the reduction of share capital”): 79,648,083 for, 24,302 against, per its Form 8-K filed December 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 79 asset managers below reported 23,012,988 for, 7,245 withheld.

FOR
FOR: 23,012,988WITHHOLD: 7,245
Largest asset managers voting on “Approve Reduction in Share Capital” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust5,066,9590 00For
BlackRock4,431,6090 00For
Vanguard3,148,9710 00For
Fidelity2,631,8270 00For
Charles Schwab1,151,4230 00For
TIAA928,7220 00For
Victory Capital531,2530 00For
OBERWEIS FUNDS424,9410 00For
Federated Hermes398,7580 00For
Pacer Funds Trust345,9400 00For
DRIEHAUS MUTUAL FUNDS344,5120 00For
American Century314,6940 00For
Royce305,7100 00For
Equitable268,3360 00For
Dimensional239,3090 00For
SEI238,0870 00For
QUANTITATIVE MASTER SERIES LLC202,4920 00For
Lincoln Financial180,3220 00For
Thrivent140,2340 00For
Calamos112,8560 00For
Principal Exchange-Traded Funds92,8670 00For
Prudential/PGIM81,7480 00For
Northern Trust80,2660 00For
TARGET PORTFOLIO TRUST77,7000 00For
Voya74,0260 00For

Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.

16. Authorize Issue of Equity

No official matchCAPITAL STRUCTURE

Meeting held December 11, 2025.

100% of fund votes cast · no official result

FOR
Details: votes by 53 asset managers

The 53 asset managers below reported 15,701,308 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 15,701,308
Largest asset managers voting on “Authorize Issue of Equity” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust5,066,9590 00For
Vanguard3,148,9710 00For
Fidelity2,631,8270 00For
TIAA928,7220 00For
Victory Capital531,2530 00For
OBERWEIS FUNDS424,9410 00For
DRIEHAUS MUTUAL FUNDS344,5120 00For
American Century314,6940 00For
Royce305,7100 00For
Equitable268,3360 00For
Dimensional239,3090 00For
Lincoln Financial180,3220 00For
Thrivent140,2340 00For
Principal Exchange-Traded Funds92,8670 00For
Northern Trust80,2660 00For
Voya74,0260 00For
RBB FUND, INC.66,7510 00For
OLD WESTBURY FUNDS INC66,6290 00For
AIG/SunAmerica59,7110 00For
Prudential/PGIM59,4500 00For
State Street44,7030 00For
Nationwide44,4950 00For
Brighthouse43,4280 00For
MFS43,1220 00For
JPMorgan42,5060 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

17. 3. To authorise (a) the paying up, allotment and issuance of New Indivior Shares, and (b) the Directors to allot such…

Outcome not verifiedCAPITAL STRUCTUREReported outcome: Not verified

Meeting held December 11, 2025.

99% Majority: yes · of votes cast

FOR 99%
FOR: 78,547,077AGAINST: 1,126,760
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: To authorise (a) the paying up, allotment and issue of New Indivior Shares and (b) to authorise the Directors to allot such New Indivior Shares

Indivior Pharmaceuticals, Inc.’s own tally for this item (“3. To authorise (a) the paying up, allotment and issuance of New Indivior Shares, and (b) the Directors to allot such New Indivior Shares”): 78,547,077 for, 1,126,760 against, per its Form 8-K filed December 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 7,311,680 for, 7,245 withheld.

FOR
FOR: 7,311,680WITHHOLD: 7,245
Largest asset managers voting on “To authorise (a) the paying up, allotment and issue of New Indivior Shares and (b) to authorise the Directors ” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock4,431,6090 00For
Charles Schwab1,151,4230 00For
Federated Hermes398,7580 00For
Pacer Funds Trust345,9400 00For
SEI238,0870 00For
QUANTITATIVE MASTER SERIES LLC202,4920 00For
Calamos112,8560 00For
TARGET PORTFOLIO TRUST77,7000 00For
Global X58,2890 00For
TRUST FOR PROFESSIONAL MANAGERS57,8690 00For
Jackson National51,3210 00For
John Hancock37,7040 00For
Bridge Builder Trust28,1300 00For
MASTER INVESTMENT PORTFOLIO27,9170 00For
Prudential/PGIM22,2980 00For
New York Life16,8060 00For
Russell Investments10,9070 00For
Venerable Variable Insurance Trust9,9140 00For
TIFF INVESTMENT PROGRAM8,7320 00For
NYLIM VP FUNDS TRUST8,0650 00For
Brighthouse00 07,245Withhold
GoldenTree Opportunistic Credit Fund3,3180 00For
Nationwide2,9620 00For
Simplify Exchange Traded Funds2,6710 00For
WILSHIRE MUTUAL FUNDS INC2,0020 00For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

18. 2. To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy…

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Meeting held May 13, 2026.

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 90,364,566AGAINST: 1,324,996
Details: description as filed, official tally, votes by 292 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.

Indivior Pharmaceuticals, Inc.’s own tally for this item (“2. To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement (Say-on-Pay)”): 90,364,566 for, 1,324,996 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 84 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,290,2317 70For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle194,1460 00For
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Northern Trust86,1720 00For

Fund voting reports, all 84 managers: 35,389,665 for, 9,855 against, 19,760 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 231 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
OAKTREE CAPITAL MANAGEMENT LP6,977,6580 00For
Two Seas Capital LP5,640,4610 00For
FULLER & THALER ASSET MANAGEMENT, INC.5,553,6910 00For
BlackRock4,413,9670 00For
DEERFIELD MANAGEMENT COMPANY, L.P.3,097,7900 00For
Madison Avenue Partners, LP2,993,5100 00For
GEODE CAPITAL MANAGEMENT, LLC2,894,8310 00For
State Street2,412,6803,925 00For
Newtyn Management, LLC2,194,2050 00For
Citadel2,178,5740 00For
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND1,900,7120 00For
Goldman Sachs1,203,7050 00For
Charles Schwab1,191,4840 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1,177,0240 00For
Federated Hermes1,155,1148,792 00For
GENDELL JEFFREY L1,096,3430 00For
DRIEHAUS CAPITAL MANAGEMENT LLC1,094,9680 00For
Northern Trust1,040,4730 00For
ACADIAN ASSET MANAGEMENT LLC1,038,5840 00For
Nuveen945,5160 00For
Vanguard935,8890 00For
PRINCIPAL GLOBAL INVESTORS772,5180 00For
Soleus Capital Management, L.P.656,0590 00For
MELLON INVESTMENTS Corp625,2240 00For
Fidelity524,9230 00For

Institutional-manager reports, all 231 managers: 63,108,539 for, 530,255 against, 6,839 abstained, 143,948 1 year. Showing the 25 largest; see all in the interactive database.

19. 3. To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our…

Meeting held May 13, 2026.

Combines 4 wordings of this item as funds reported it.

100% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 290 asset managers

Description as filed by funds: To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 84 asset managers voting on “To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation o” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock00 00--
Vanguard00 00--
Capitol Series Trust00 00--
Fidelity00 00--
State Street00 00--
Charles Schwab00 00--
TIAA00 00--
Federated Hermes00 00--
DRIEHAUS MUTUAL FUNDS00 00--
Bridge Builder Trust00 00--
Dimensional00 00--
American Century00 00--
Equitable00 00--
Jackson National00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
Columbia Threadneedle00 00--
Lincoln Financial71,7200 00For
Prudential/PGIM00 00--
Principal Exchange-Traded Funds00 00--
OLD WESTBURY FUNDS INC00 00--
BNY Mellon00 00--
Principal00 00--
SEI00 00--
MFS00 00--
Northern Trust00 00--

Fund voting reports, all 84 managers: 111,224 for, 19,753 abstained, 34,909,429 1 year, 348,607 3 year, 30,268 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 227 asset managers voting on “To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation o” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
OAKTREE CAPITAL MANAGEMENT LP00 00--
Two Seas Capital LP00 00--
FULLER & THALER ASSET MANAGEMENT, INC.00 00--
BlackRock00 00--
DEERFIELD MANAGEMENT COMPANY, L.P.00 00--
Madison Avenue Partners, LP00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
State Street00 00--
Newtyn Management, LLC00 00--
Citadel00 00--
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND00 00--
Goldman Sachs00 00--
Charles Schwab00 00--
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP00 00--
Federated Hermes00 00--
GENDELL JEFFREY L00 00--
DRIEHAUS CAPITAL MANAGEMENT LLC00 00--
Northern Trust00 00--
ACADIAN ASSET MANAGEMENT LLC00 00--
Nuveen00 00--
Vanguard00 00--
PRINCIPAL GLOBAL INVESTORS00 00--
Claret Asset Management Corp00 00--
Soleus Capital Management, L.P.00 00--
MELLON INVESTMENTS Corp00 00--

Institutional-manager reports, all 227 managers: 146,041 for, 6,776 abstained, 58,002,044 1 year, 5,640,461 unknown, 255,173 3 year. Showing the 25 largest; see all in the interactive database.

20. 4. To ratify the appointment of PricewaterhouseCoopers LLP US (PwC) as our independent registered public accounting…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Meeting held May 13, 2026.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 99,146,241AGAINST: 1,237,984
Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

Indivior Pharmaceuticals, Inc.’s own tally for this item (“4. To ratify the appointment of PricewaterhouseCoopers LLP US (PwC) as our independent registered public accounting firm for the fiscal year ending December 31, 2026”): 99,146,241 for, 1,237,984 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 35,491,835 for, 51,554 against, 19,753 abstained.

FOR
FOR: 35,491,835AGAINST: 51,554ABSTAIN: 19,753
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting f” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock12,789,4980 00For
Vanguard5,290,2397 00For
Capitol Series Trust4,481,7590 00For
Fidelity3,033,0450 00For
State Street2,054,0250 00For
Charles Schwab1,124,4710 00For
TIAA925,3720 00For
Federated Hermes804,4640 00For
DRIEHAUS MUTUAL FUNDS335,2670 00For
Bridge Builder Trust290,5600 00For
Dimensional287,4350 00For
American Century272,5860 00For
Equitable260,1480 00For
Jackson National257,8330 00For
QUANTITATIVE MASTER SERIES LLC199,4830 00For
Columbia Threadneedle194,1460 00For
Lincoln Financial165,3470 00For
Prudential/PGIM165,2570 00For
Principal Exchange-Traded Funds156,6270 00For
OLD WESTBURY FUNDS INC113,4000 00For
BNY Mellon111,2280 00For
Principal109,0260 00For
SEI108,6320 00For
MFS103,9080 00For
Empower90,7420 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

Largest Indivior Pharmaceuticals, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 121,922,058 shares outstanding at the time of that meeting.

Fund voting reports: top Indivior Pharmaceuticals, Inc. shareholders by shares voted on “Election of Directors: Barbara Ryan”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 10.49%
2Vanguard 4.34%
3Capitol Series Trust 3.68%
4Fidelity 2.49%
5State Street 1.68%
6Charles Schwab 0.92%
7TIAA 0.76%
8Federated Hermes 0.66%
9DRIEHAUS MUTUAL FUNDS 0.27%
10Bridge Builder Trust 0.24%
Institutional-manager reports: top Indivior Pharmaceuticals, Inc. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1OAKTREE CAPITAL MANAGEMENT LP 5.72%
2Two Seas Capital LP 4.63%
3FULLER & THALER ASSET MANAGEMENT, INC. 4.56%
4BlackRock 3.62%
5DEERFIELD MANAGEMENT COMPANY, L.P. 2.54%
6Madison Avenue Partners, LP 2.46%
7GEODE CAPITAL MANAGEMENT, LLC 2.37%
8State Street 1.98%
9Newtyn Management, LLC 1.80%
10Citadel 1.79%

Reported Indivior Pharmaceuticals, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Indivior Pharmaceuticals, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 15.21% 13F
Vanguard Portfolio Management 6.56% 13G
Oaktree Capital Group Holdings LP 5.83% DEF14A
Vanguard Capital Management 5.35% 13G
Madison Avenue Partners LP 5.15% DEF14A
State Street 4.02% 13F
Millennium Management 3.77% 13F
Fuller & Thaler Asset Management, Inc. 3.72% 13G
Madison Avenue International LP 3.54% 13G
Citadel Advisors 3.04% 13F

Percentages above are of 121,922,058 shares outstanding, as reported by Indivior Pharmaceuticals, Inc. on its Form 10-Q dated April 1, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Indivior Pharmaceuticals, Inc.’s 10-Q dated April 1, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Indivior Pharmaceuticals, Inc.'s 2 shareholder meetings in the 2025-2026 proxy season (held December 11, 2025 and May 13, 2026), 303 asset managers reported how they voted in their SEC Form N-PX filings, covering 5,333 separate fund positions. Their filings are grouped here into 20 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held May 13, 2026 — To approve, on an advisory basis, the compensation of our named executive officers. — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Indivior Pharmaceuticals, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2026.

Indivior Pharmaceuticals, Inc. proxy season coverage: 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.